Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: ...
Q2 2026
Jul 29, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 4, 2025